Experimental and Molecular Pathology
Use the link below to read or download ATXA Therapeutics published article on the expression and regulation of thromboxane receptors in...
- Jul 9, 2019
New paper on thromboxane receptors in prostate inflammation published in Experimental and Molecular
ATXA Therapeutics, along with members of the academic research group of CSO Prof. Therese Kinsella at University College Dublin, have...
- May 23, 2019
EIC Welcomes Entrepreneurs
PAH-HOPE CSO Prof. Therese Kinsella is in Brussels meeting fellow entrepreneurs in the EIC community at SME Phase 2 Coordinators Welcome...
- May 7, 2019
- May 2, 2019
Funding Opportunities for Breakthrough Innovation
ATXA Therapeutics Founder and CSO, Prof Therese Kinsella will represent the company at an event on the European Innovation Council...
- May 2, 2019
Irish life sciences start-ups to watch
ATXA Therapeutics Ltd is proud to be listed among the 10 interesting Irish life sciences start-ups to watch. New hope for the PAH...
- May 1, 2019
Keeping up with the competition
ATXA Therapeutics Ltd CEO Dr Ivan Coulter on keeping up with the competition in the pharma space as featured in today's Leaders' Insight...
- Apr 8, 2019
Innovation Summit
The ATXA Therapeutics team is looking forward to attending the MedTech Strategist Innovation Summit Dublin 2019. 1 more day to go ! This...
- Mar 14, 2019
ATXA attends BioCapital Europe
ATXA Therapeutics is attending BioCapital Europe in Amterdam today. #Lifesciences #investment
- Feb 28, 2019
Rare Disease Day
Today is Rare Disease Day 2019. #ShowYourRare. The aim is to raise awareness about rare diseases. ATXA is on a mission to offer new hope...
- Feb 25, 2019
Life Sciences CEO Conference
ATXA is attending the Sachs Associates 12th Annual European Life Sciences CEO Conference at the Hilton Airport Zurich Hotel